KCTD8 anticorps (C-Term)
Aperçu rapide pour KCTD8 anticorps (C-Term) (ABIN953023)
Antigène
Voir toutes KCTD8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 441-470, C-Term
-
Specificité
- This antibody recognizes Human KCTD8 (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 441-470 amino acids from the C-terminal region of human KCTD8
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- KCTD8 (Potassium Channel Tetramerisation Domain Containing 8 (KCTD8))
-
Autre désignation
- KCTD8
-
Sujet
- Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization (By similarity).Synonyms: BTB/POZ domain-containing protein KCTD8
-
Poids moléculaire
- 52440 Da
-
ID gène
- 386617
-
NCBI Accession
- NP_938167
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling
Antigène
-